• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳氧血红蛋白:临床医生入门指南。

Carboxyhemoglobin: a primer for clinicians.

作者信息

Hampson Neil B

机构信息

Center for Hyperbaric Medicine, Virginia Mason Medical Center, Seattle, Washington.

出版信息

Undersea Hyperb Med. 2018 Mar-Apr;45(2):165-171.

PMID:29734568
Abstract

One of carbon monoxide's several mechanisms of toxicity is binding with circulating hemoglobin to form carboxyhemoglobin, resulting in a functional anemia. While patients with carbon monoxide poisoning are often said to be "cherry-red," such discoloration is rarely seen. Carboxyhemoglobin levels cannot be measured with conventional pulse oximetry, can be approximated with pulse CO-oximetry, and are most accurately measured with a laboratory CO-oximeter. Carboxyhemoglobin levels are quite stable and can be accurately measured on a transported blood sample. For clinical purposes, arterial and venous carboxyhemoglobin levels can be considered to be equivalent. Carboxyhemoglobin levels are typically lower than 2% in non-smokers and lower than 5% in smokers. A level over 9% is almost always due to exogenous carbon monoxide exposure, even among smokers. Conversely, a low level does not exclude significant exposure under certain circumstances. As carboxyhemoglobin levels of poisoned patients do not correlate with symptoms or outcome, their greatest utility is a marker of exposure.

摘要

一氧化碳的多种毒性机制之一是与循环中的血红蛋白结合形成碳氧血红蛋白,从而导致功能性贫血。虽然一氧化碳中毒患者常被说成是“樱桃红”,但这种变色很少见。碳氧血红蛋白水平无法用传统脉搏血氧饱和度测定法测量,可用脉搏碳氧血氧饱和度测定法大致估算,最准确的测量方法是使用实验室碳氧血红蛋白测定仪。碳氧血红蛋白水平相当稳定,在转运的血样上也能准确测量。出于临床目的,动脉血和静脉血中的碳氧血红蛋白水平可视为等同。非吸烟者的碳氧血红蛋白水平通常低于2%,吸烟者低于5%。即使在吸烟者中,超过9%的水平几乎总是由于外源性一氧化碳暴露所致。相反,在某些情况下,低水平并不能排除大量暴露。由于中毒患者的碳氧血红蛋白水平与症状或预后无关,其最大作用是作为暴露的标志物。

相似文献

1
Carboxyhemoglobin: a primer for clinicians.碳氧血红蛋白:临床医生入门指南。
Undersea Hyperb Med. 2018 Mar-Apr;45(2):165-171.
2
Emergency department management of suspected carbon monoxide poisoning: role of pulse CO-oximetry.急诊疑似一氧化碳中毒的管理:脉搏 CO-血氧仪的作用。
Respir Care. 2013 Oct;58(10):1614-20. doi: 10.4187/respcare.02313. Epub 2013 Mar 19.
3
Finding needles in a haystack: a case series of carbon monoxide poisoning detected using new technology in the emergency department.大海捞针:急诊科应用新技术检测一氧化碳中毒的病例系列报道
Clin Toxicol (Phila). 2008 Jun;46(5):461-9. doi: 10.1080/15563650701725110.
4
New strategy for carbon monoxide poisoning diagnosis: Carboxyhemoglobin (COHb) vs Total Blood Carbon Monoxide (TBCO).一氧化碳中毒诊断的新策略:碳氧血红蛋白(COHb)与总血一氧化碳(TBCO)。
Forensic Sci Int. 2020 Jan;306:110063. doi: 10.1016/j.forsciint.2019.110063. Epub 2019 Nov 15.
5
False positive rate of carbon monoxide saturation by pulse oximetry of emergency department patients.急诊患者脉搏血氧饱和度仪假阳性率。
Respir Care. 2013 Feb;58(2):232-40. doi: 10.4187/respcare.01744.
6
Performance of the RAD-57 pulse CO-oximeter compared with standard laboratory carboxyhemoglobin measurement.RAD-57 脉冲 CO- 氧合仪与标准实验室碳氧血红蛋白测量的性能比较。
Ann Emerg Med. 2010 Oct;56(4):382-8. doi: 10.1016/j.annemergmed.2010.03.041. Epub 2010 Jun 3.
7
[Experience in employing pulse CO-Oximetry].[使用脉搏血氧饱和度仪的经验]
Masui. 2008 May;57(5):621-3.
8
Noninvasive pulse CO-oximetry expedites evaluation and management of patients with carbon monoxide poisoning.无创脉搏 CO-血氧仪可加快一氧化碳中毒患者的评估和治疗。
Am J Emerg Med. 2012 Nov;30(9):2021-4. doi: 10.1016/j.ajem.2012.03.026. Epub 2012 May 23.
9
The pulse oximetry gap in carbon monoxide intoxication.一氧化碳中毒时的脉搏血氧饱和度差值
Ann Emerg Med. 1994 Aug;24(2):252-5. doi: 10.1016/s0196-0644(94)70137-7.
10
Non-invasive monitoring of carboxyhemoglobin during hyperbaric oxygen therapy.高压氧治疗期间碳氧血红蛋白的无创监测。
Undersea Hyperb Med. 2021 First Quarter;48(1):33-42. doi: 10.22462/01.03.2021.4.

引用本文的文献

1
Carbon Monoxide Poisoning: Never a Bad Time to Refresh Your Knowledge.一氧化碳中毒:温故知识永不为迟。
Mo Med. 2025 Jul-Aug;122(4):262-265.
2
Contactless in vitro detection of carboxyhemoglobin using hyperspectral imaging (HSI).使用高光谱成像(HSI)对碳氧血红蛋白进行非接触式体外检测。
Forensic Sci Med Pathol. 2025 Feb 4. doi: 10.1007/s12024-025-00949-1.
3
Carbon Monoxide as a Potential Therapeutic Agent: A Molecular Analysis of Its Safety Profiles.一氧化碳作为一种有潜力的治疗药物:对其安全性的分子分析。
J Med Chem. 2024 Jun 27;67(12):9789-9815. doi: 10.1021/acs.jmedchem.4c00823. Epub 2024 Jun 12.
4
Pathological alterations and COHb evaluations as tools for investigating fire-related deaths in veterinary forensic pathology.病理改变和碳氧血红蛋白评估作为兽医法医病理学中调查与火灾相关死亡的工具。
Front Vet Sci. 2024 May 21;11:1396540. doi: 10.3389/fvets.2024.1396540. eCollection 2024.
5
Demographics and clinical characteristics of carbon monoxide poisoning for patients attending in the emergency department at a tertiary hospital in Riyadh, Saudi Arabia.沙特阿拉伯利雅得一家三级医院急诊科一氧化碳中毒患者的人口统计学和临床特征。
Int J Emerg Med. 2024 Feb 26;17(1):25. doi: 10.1186/s12245-024-00600-w.
6
Carboxyhemoglobin (COHb): Unavoidable Bystander or Protective Player?碳氧血红蛋白(COHb):不可避免的旁观者还是保护性参与者?
Antioxidants (Basel). 2023 May 31;12(6):1198. doi: 10.3390/antiox12061198.
7
Recent advancements in critical care: Part I.重症监护的最新进展:第一部分。
Indian J Anaesth. 2023 Jan;67(1):102-109. doi: 10.4103/ija.ija_1005_22. Epub 2023 Jan 21.
8
The Trend of Arterial Carboxyhemoglobin in Non-smokers as a Prognostic Tool in Severe COVID-19 Patients: A Single-Centre Prospective Study.非吸烟者动脉碳氧血红蛋白水平变化趋势作为重症 COVID-19 患者预后评估工具的单中心前瞻性研究
Cureus. 2022 Nov 28;14(11):e31955. doi: 10.7759/cureus.31955. eCollection 2022 Nov.
9
Snowfall and Carbon Monoxide Poisoning in Murree Pakistan.巴基斯坦穆里的降雪与一氧化碳中毒
Pak J Med Sci. 2022 Nov-Dec;38(8):2386. doi: 10.12669/pjms.38.8.6936.
10
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response.一氧化碳信号转导:结合结合亲和力、浓度和生物学反应考察其与各种分子靶标的相互作用。
Pharmacol Rev. 2022 Jul;74(3):823-873. doi: 10.1124/pharmrev.121.000564.